Participant in Covid vaccine trial sent legal notice to Serum Institute, claiming neurological & psychological symptoms, seeking Rs 5 crore in compensation.
Poonawalla, CEO of the Serum Institute of India, disclosed that the pharma giant will apply for emergency authorisation of the Covid-19 vaccine in the next 2 weeks.
Chennai-based participant also sends legal notice to ICMR, DCGI, AstraZeneca & Oxford University to stop testing, manufacturing & distributing vaccine.
The comments came after AstraZeneca & Oxford University acknowledged a manufacturing error that is raising doubts about preliminary results of their experimental Covid-19 vaccine.
Earlier this month, the Serum Institute of India had paused the clinical trials of Oxford vaccine candidate in India. On 15 September, the DCGI gave permission to resume the trial.
According to government reply in Lok Sabha, the pilot phase of PMIS is being used to test concepts, strategies and systems before a full-scale implementation of the scheme.
Order for 87 MALE drones will be split between 2 Indian firms in 64:36 ratio to ensure there are 2 independent manufacturing lines with at least 60% indigenous components.
The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.
COMMENTS